These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11672954)

  • 1. Characterization of soft gelatin capsules by thermal analysis.
    Nazzal S; Wang Y
    Int J Pharm; 2001 Nov; 230(1-2):35-45. PubMed ID: 11672954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation.
    Barakat NS
    Drug Dev Ind Pharm; 2006 Aug; 32(7):865-76. PubMed ID: 16908424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules.
    Mei X; Etzler FM; Wang Z
    Int J Pharm; 2006 Nov; 324(2):128-35. PubMed ID: 16844327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
    Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules.
    Chen FJ; Etzler FM; Ubben J; Birch A; Zhong L; Schwabe R; Dudhedia MS
    J Pharm Sci; 2010 Jan; 99(1):128-41. PubMed ID: 19455627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability study of hard gelatin capsules containing retinoic acid.
    Caviglioli G; Parodi B; Posocco V; Cafaggi S; Bignardi G
    Drug Dev Ind Pharm; 2000 Sep; 26(9):995-1001. PubMed ID: 10914325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal characterisation of gelatin extracted from yellowfin tuna skin and commercial mammalian gelatin.
    Rahman MS; Al-Saidi GS; Guizani N
    Food Chem; 2008 May; 108(2):472-81. PubMed ID: 26059124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the residual ethanol in hydroalcoholic sealed hard gelatin capsules by static headspace gas chromatography with immiscible binary solvents.
    Li J; Shao S; Solorzano M; Allmaier GJ; Kurtulik PT
    J Chromatogr A; 2009 Apr; 1216(15):3328-36. PubMed ID: 19264315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G; Csontos B; Sovány T; Regdon G; Bényei A; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Nguyen TLP; Vecsernyés M; Fenyvesi F
    AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
    Chong RH; Jones BE; Díez F; Birchall JC; Coulman SA
    Int J Pharm; 2016 Mar; 500(1-2):316-25. PubMed ID: 26806464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emulsion type new vehicle for soft gelatin capsule available for preclinical and clinical trials: effects of PEG 6000 and PVP K30 on physicochemical stability of new vehicle.
    Amemiya T; Mizuno S; Yuasa H; Watanabe J
    Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):492-7. PubMed ID: 10319428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.